Cargando…

PSMA1, a Poor Prognostic Factor, Promotes Tumor Growth in Lung Squamous Cell Carcinoma

Lung squamous cell carcinoma (LUSC) has a poor clinical prognosis and lacks effective targeted therapy. This study is aimed at investigating the role of PSMA1 (proteasome subunit alpha type-1) in LUSC. The differential expression genes (DEGs) in LUSC were retrieved from The Cancer Genome Atlas (TCGA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhao, Wang, Wuping, Zhou, Yanwu, Li, Linfeng, Zhou, Wolong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918360/ https://www.ncbi.nlm.nih.gov/pubmed/36776923 http://dx.doi.org/10.1155/2023/5386635

Ejemplares similares

TGFBI Promotes Tumor Growth and is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Bing-jie, et al.
Publicado: (2019)

Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients
por: Yi, Bin, et al.
Publicado: (2023)

ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma
por: Zheng, Meng, et al.
Publicado: (2020)

PSMA1 mediates tumor progression and poor prognosis of gastric carcinoma by deubiquitinating and stabilizing TAZ
por: Yang, Qinyu, et al.
Publicado: (2022)

Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction
por: Li, Linfeng, et al.
Publicado: (2023)

SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2020)

MAPK6-AKT signaling promotes tumor growth and resistance to mTOR kinase blockade
por: Cai, Qinbo, et al.
Publicado: (2021)

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
por: Zhang, Qingyi, et al.
Publicado: (2019)

NPLOC4 is a potential target and a poor prognostic signature in lung squamous cell carcinoma
por: Wang, Naixue, et al.
Publicado: (2023)

Estrogen receptor beta promotes lung cancer invasion via increasing CXCR4 expression
por: Liu, Shiqing, et al.
Publicado: (2022)

BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)

Upregulation of SIX4 indicates poor clinical outcome and promotes tumor growth and cell metastasis in esophageal squamous cell carcinoma
por: Li, Yanping, et al.
Publicado: (2021)

Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma
por: Cao, Xinghua, et al.
Publicado: (2021)

Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung
por: Holzer, Timothy R., et al.
Publicado: (2013)

PD-L1 expression as poor prognostic factor in patients with non-squamous non-small cell lung cancer
por: Zhou, Cuiling, et al.
Publicado: (2017)

Invasion Types Are Associated With Poor Prognosis in Lung Squamous Carcinoma Patients
por: Zhao, Yang, et al.
Publicado: (2015)

Prognostic Value of Vascular-Expressed PSMA and CD248 in Urothelial Carcinoma of the Bladder
por: Li, Yu, et al.
Publicado: (2021)

The prognostic landscape of tumor-infiltrating immune cells in lung squamous cell carcinoma
por: Guo, Liang, et al.
Publicado: (2021)

High Prognostic Value of (68)Ga-PSMA PET/CT in Renal Cell Carcinoma and Association with PSMA Expression Assessed by Immunohistochemistry
por: Gasparro, Donatello, et al.
Publicado: (2023)

Construction and validation of a tumor mutational burden and immune-related prognostic model for predicting the prognosis of patients with lung squamous cell carcinoma
por: Zhou, Yuting, et al.
Publicado: (2023)

Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma
por: Li, Juan, et al.
Publicado: (2017)

PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
por: Bychkov, Andrey, et al.
Publicado: (2017)

Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients
por: MASUDA, RYOTA, et al.
Publicado: (2012)

The Indication of Poor Prognosis by High Expression of ENO1 in Squamous Cell Carcinoma of the Lung
por: Huang, Wan-Ying, et al.
Publicado: (2021)

Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma
por: Sumita, Yoshimasa, et al.
Publicado: (2018)

High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma
por: Chen, Shuwei, et al.
Publicado: (2020)

PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma
por: Qian, Zhaoye, et al.
Publicado: (2019)

Prognostic value of immune-related genes in the tumor microenvironment of lung adenocarcinoma and lung squamous cell carcinoma
por: Qu, Yan, et al.
Publicado: (2020)

Cuproptosis Depicts Immunophenotype and Predicts Immunotherapy Response in Lung Adenocarcinoma
por: Zhou, Wolong, et al.
Publicado: (2023)

Keratinization of Lung Squamous Cell Carcinoma Is Associated with Poor Clinical Outcome
por: Park, Hye Jung, et al.
Publicado: (2017)

Ideal prognostic model in lung squamous cell carcinoma
por: Kinoshita, Tomonari
Publicado: (2020)

Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas
por: Wang, Jingshu, et al.
Publicado: (2017)

EZH2 inhibition promotes tumor immunogenicity in lung squamous cell carcinomas
por: DuCote, Tanner J., et al.
Publicado: (2023)

Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma
por: Shen, Qi, et al.
Publicado: (2020)

Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
por: Hu, Zele, et al.
Publicado: (2020)

Low-density lipoprotein promotes lymphatic metastasis of esophageal squamous cell carcinoma and is an adverse prognostic factor
por: Deng, Hongbin, et al.
Publicado: (2019)

RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma
por: Wang, Wei, et al.
Publicado: (2017)

MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade
por: Wang, Wei, et al.
Publicado: (2022)

Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus
por: Makino, T, et al.
Publicado: (2009)

PRKAR1A is a functional tumor suppressor inhibiting ERK/Snail/E-cadherin pathway in lung adenocarcinoma
por: Wang, Shaoqiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_85un5cs80favkfqep370htgga8